Try our mobile app

General information

Sector: Health Care

The company is available at Interactive Brokers

Aspen Pharmacare Holdings Limited (JSE:APN) is a global specialty and branded pharmaceutical company, improving the health of patients across the world through its high quality and affordable products. Active at every stage of the value chain, Aspen is uniquely diversified by geography, product and manufacturing capability, positioning it well to maximise the value it create for the business and its diverse stakeholders.

Aspen supplies medicines to more than 150 countries and has 70 established business operations in 55 countries. 

The company focuses on marketing and manufacturing a broad range of post-patent, branded medicines and domestic brands covering both hospital and consumer markets through its key business segments:

Commercial Pharmaceuticals

Regional Brands – a widely diverse segment comprising predominantly leading domestic brands in the Sub-Saharan Africa, Australasia and Latin American territories.

Sterile Focus Brands – focused on niche, sterile products comprising our Anaesthetics Brands and Thrombosis Brands.


  • Anaesthetics – includes a broad range of general anaesthetics, muscle relaxants as well as a number of local anaesthetics including topical agents.
  • Thrombosis – comprises a broad range of specialist injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors and heparin derivatives.


 

Manufacturing

Contract and supply of chemical and biochemical APIs and finished dose form (“FDF”) pharmaceuticals for third parties



  • Bad financial results growth rate -3.4% (average between last period year over year growth for revenue and EBITDA), there is slowdown compared to average historical growth rates (-0.0%)
  • Dividend yield for the last twelve months 0.0%
  • Free cash flow yield -0.8% (LTM)
  • Share price is 68.4% higher than minimum and 19.6% lower than maximum for the last 3 years
  • The company is overvalued by EV / LTM EBITDA multiple compared to target level (9.8x vs
    )
  • Fundamental value created in LTM (estimate)

Key Financials

Share price, ZAR:  (0.0%)220.71
Share price, USD: 11.77
Common stocks: 446 241 675

Dividend Yield:  0.0%
FCF Yield LTM: -0.8%
EV / LTM EBITDA: 9.8x
Last revenue growth (y/y):  -5.1%
Last growth of EBITDA (y/y):  -1.7%
Historical revenue growth:  -2.0%
Historical growth of EBITDA:  -3.8%
Target EV / EBITDA (hist percentile):
Fundamental value created in LTM:
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 5 250
Net Debt ($m): 976
EV (Enterprise Value): 6 226
EBITDA LTM ($m): 635
EV / LTM EBITDA: 9.8x
Price to Book: 1.15x

Revenue and EBITDA

Semi-Annual values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment ZAR per share

Multiple and potential

EV / EBITDA

Potential dynamics

TechCentral Headlines

SA’s Covid vaccine plant may shut due to lack of demand

African efforts to produce Covid-19 vaccines on the continent may face a setback amid a dearth of orders for the injections.

2022-04-14 15:30 +02:00
by Janice Kew

JSE:APN JSE:AVI JSE:ISA

SA delays new Covid vaccine orders amid widespread hesitancy

South Africa has asked Johnson & Johnson and Pfizer to delay delivery of Covid-19 vaccines because it now has too much stock.

2021-11-24 11:14 +02:00
by Promit Mukherjee

JSE:APN JSE:AVI

Spectrum allocation among new finance minister’s top priorities

Enoch Godongwana says topping his “to-do list” to bolster economic growth includes reforming the country’s electricity supply and assigning spectrum.

2021-10-01 16:30 +02:00
by Akhona Matshoba

JSE:APN JSE:AVI JSE:ISA

EOH to list on A2X Markets

JSE-listed IT services group EOH Holdings plans a secondary listing on A2X Markets, with its shares to available to trade from Friday, 13 August.

2021-08-05 11:30 +02:00
by Staff Reporter

JSE:PRX JSE:NPN JSE:SOL JSE:SLM JSE:APN JSE:MRP JSE:MTM JSE:AVI JSE:JSE JSE:FBR JSE:EOH JSE:ISA

Level-4 lockdown extended by two weeks: What Ramaphosa said

President Cyril Ramaphosa extended bans on alcohol sales and most public gatherings for two weeks as the government struggles to bring a third wave of coronavirus infections under control.

2021-07-12 06:18 +02:00
by Agency Staff

JSE:APN JSE:AVI JSE:MPT

South Africa falling behind in race to secure Covid-19 vaccines

South Africa, the country with the worst confirmed coronavirus outbreak in Africa, is yet to provide clarity on how it plans to order vaccines, even as the global race to secure inoculations accelerates.

2020-12-03 06:28 +02:00
by Agency Staff

JSE:APN JSE:AVI

Old Mutual says local shares oversold, including MTN and Vodacom

South Africa’s weak economy and poor growth prospects have hidden the “phenomenal” potential for the shares in some locally focused companies to deliver returns for investors, according to Old Mutual Investment Group.

2020-11-04 13:00 +02:00
by Agency Staff

JSE:MTN JSE:VOD JSE:SHP JSE:APN JSE:OMU JSE:ITE JSE:MSM JSE:RBX JSE:ISA JSE:SSK

South Africa’s Aspen working to ensure supply of promising Covid-19 drug

Aspen Pharmacare is working to ensure it can manage demand for a generic anti-inflammatory drug that was shown to improve survival in Covid-19 patients.

2020-06-18 09:47 +02:00
by Agency Staff

JSE:APN JSE:AVI

WhatsApp deployed as coronavirus spreads in South Africa

About two weeks ago, Praekelt.org, a non-profit foundation that runs a WhatsApp service on maternal well-being for South Africa’s health department, proposed setting up a similar programme to keep people informed about the coronavirus.

2020-03-23 06:22 +02:00
by Agency Staff

JSE:APN JSE:MEI JSE:LHC JSE:AVI JSE:NTC JSE:ISA

Top CEOs’ tips to the president to fix the economy

South African business leaders are in harmony on what the country needs after this week’s elections.

2019-05-06 07:31 +02:00
by Agency Staff

JSE:AGL JSE:FSR JSE:VOD JSE:SLM JSE:APN JSE:INP JSE:OMU JSE:INL JSE:MSM JSE:ISA

EOH, Blue Label among JSE’s worst performers

It’s not even the end of the first quarter and already there’s a plethora of once-significant South African companies that have either collapsed or had their share prices hit the wall.

2019-03-13 12:59 +02:00
by Agency Staff

JSE:AGL JSE:AMS JSE:IMP JSE:APN JSE:SNH JSE:JSE JSE:BLU JSE:EOH JSE:TON

Reuters Headlines

Novo Nordisk contracts Aspen to produce insulin for Africa

LONDON (Reuters) -Novo Nordisk has contracted Aspen Pharmacare to produce human insulin on its behalf in South Africa for export to African countries through a low-cost government tender system, the Danish drugmaker said on Tuesday.

2023-09-19

JSE:APN JSE:AVI JSE:ISA

Novo Nordisk contracts South Africa`s Aspen to produce insulin for African nations

Novo Nordisk has contracted Aspen Pharmacare to produce human insulin on its behalf in South Africa for export to African countries through a low-cost government tender system, the Danish drugmaker said on Tuesday.

2023-09-19

JSE:APN JSE:AVI JSE:ISA

S.Africa`s Aspen set for deals to revive idled production lines

JOHANNESBURG (Reuters) -South African drugmaker Aspen Pharmacare is close to signing four partnerships to revive its COVID-19 vaccine production lines that are generating no revenues, its CEO said, sending its shares up almost 10% in the day.

2023-03-01

JSE:APN JSE:ISA

Africa CDC hopeful Aspen will get COVID vaccine orders

JOHANNESBURG (Reuters) -Africa`s top public health body said on Thursday it was hopeful South African pharmaceutical firm Aspen Pharmacare would get orders for its own brand COVID-19 vaccine.

2022-08-11

JSE:APN

Aspen COVID vaccine lines risk going idle as J&J orders dwindle

JOHANNESBURG (Reuters) -South Africa`s Aspen Pharmacare`s COVID-19 vaccine production lines may soon go idle, and without any new orders it could be forced to pivot to manufacturing other products, a senior executive said on Wednesday.

2022-08-10

JSE:APN

UPDATE 1-Aspen COVID vaccine lines risk going idle as J&J orders dwindle

* Company cannot maintain idle production lines indefinitely (Updates with J&J and additional Aspen executive comment)

2022-08-10

JSE:APN JSE:AVI JSE:ISA

S.Africa`s Aspen to halt COVID vaccine output as J&J orders dry up

South Africa`s Aspen Pharmacare will stop making COVID-19 vaccines from the end of this month due to a lack of orders, a senior executive said, further undermining Africa`s already meager capacity to produce doses.

2022-08-10

JSE:APN

S.Africa`s president says agencies should order Africa-made vaccines

JOHANNESBURG (Reuters) -International agencies and charitable foundations providing COVID-19 vaccines for Africa should order African-made vaccines, South African President Cyril Ramaphosa told a global COVID-19 summit on Thursday.

2022-05-12

JSE:APN JSE:AVI JSE:ISA

S.Africa`s Aspen to slash COVID vaccine capacity within 6 weeks if no orders - CEO

Aspen Pharmacare will switch about half of its COVID-19 vaccine production capacity onto other products if demand doesn`t pick up within six weeks, its CEO warned, as South Africa`s president and health officials urged more Africans to take up the shots.

2022-05-05

JSE:APN JSE:AVI JSE:ISA

Africa CDC urges COVID-19 vaccine buyers to order from S.Africa`s Aspen

Africa`s top public health body urged all those purchasing COVID-19 vaccines for the continent to place orders with South Africa`s Aspen Pharmacare, saying the market was key to developing vaccine manufacturing on the continent.

2022-05-05

JSE:APN

S.Africa nears 5-year investment goal -president

JOHANNESBURG (Reuters) -South Africa is close to reaching a five-year target for new investment, President Cyril Ramaphosa said on Thursday as he sought to drum up further backing for the pandemic hobbled economy.

2022-03-24

JSE:AGL JSE:IMP JSE:APN JSE:AVI

UPDATE 2-S.Africa nears 5-year investment goal -president

* New investments span manufacturing, mining, pharma sectors (Updates with new investment figures, additional quote from Ramaphosa)

2022-03-24

JSE:AGL JSE:IMP JSE:APN JSE:AVI

S.Africa`s Aspen to supply its own branded COVID-19 vaccine by June

JOHANNESBURG (Reuters) -South Africa`s Aspen Pharmacare will start supplying its branded COVID-19 vaccine to African nations by June, its chief executive told Reuters on Wednesday, after the drugmaker reported a 37% rise in profit for the half-year to Dec. 31.

2022-03-09

JSE:APN JSE:AVI

UPDATE 2-S.Africa`s Aspen to supply its own branded COVID-19 vaccine by June

* Aspen shares up 5% as half year profit jumps by 37% (Recasts with CEO interview)

2022-03-09

JSE:APN JSE:ISA

Billionaire Soon-Shiong opens new vaccine plant in South Africa

CAPE TOWN (Reuters) -South African-American businessman Patrick Soon-Shiong opened a new vaccine plant in Cape Town on Wednesday, intended to help his local NantSA company make COVID-19 shots in future and address the continent`s deadly dearth of manufacturing capacity.

2022-01-19

JSE:APN JSE:AVI

UPDATE 2-Billionaire Soon-Shiong opens new vaccine plant in South Africa

South African-American businessman Patrick Soon-Shiong opened a new vaccine plant in Cape Town on Wednesday, intended to help his local NantSA company make COVID-19 shots in future and address the continent`s deadly dearth of manufacturing capacity.

2022-01-19

JSE:APN JSE:AVI

Billionaire Soon-Shiong opens new vaccine plant in South Africa

South African-American businessman Patrick Soon-Shiong opened a new vaccine plant in Cape Town on Wednesday, intended to help his local NantSA company make COVID-19 shots in future and redress the continent`s lack of manufacturing capacity.

2022-01-19

JSE:APN JSE:AVI

S.Africa`s Aspen signs deal paving way for J&J COVID vaccine licence

South Africa`s Aspen Pharmacare took a step towards a licensing deal to package and sell Johnson & Johnson`s COVID-19 vaccine in Africa, announcing on Tuesday it had signed non-binding terms with subsidiaries of the U.S. drugmaker.

2021-11-30

JSE:APN JSE:AVI JSE:ISA

South Africa delays COVID vaccine deliveries as inoculations slow

JOHANNESBURG (Reuters) -South Africa has asked Johnson & Johnson and Pfizer to delay delivery of COVID-19 vaccines because it now has too much stock, health ministry officials said, as vaccine hesitancy slows an inoculation campaign.

2021-11-24

JSE:APN JSE:AVI

EXCLUSIVE-South Africa delays COVID vaccine deliveries as inoculations slow

South Africa has asked Johnson & Johnson and Pfizer to delay delivery of COVID-19 vaccines because it now has too much stock, health ministry officials said, as vaccine hesitancy slows an inoculation campaign.

2021-11-24

JSE:APN JSE:AVI

S.Africa`s Aspen aims to sharply increase COVID-19 vaccine capacity

GQEBERHA, South Africa (Reuters) -South Africa`s Aspen Pharmacare is aiming to ramp up its COVID-19 vaccine manufacturing capacity to 1.3 billion doses a year by February 2024, up from a current annual output of around 250 million doses, the company`s CEO told Reuters on Monday.

2021-10-27

JSE:APN JSE:AVI JSE:ISA

RPT-UPDATE 2-S.Africa`s Aspen aims to sharply increase COVID-19 vaccine capacity

South Africa`s Aspen Pharmacare is aiming to ramp up its COVID-19 vaccine manufacturing capacity to 1.3 billion doses a year by February 2024, up from a current annual output of around 250 million doses, the company`s CEO told Reuters on Monday.

2021-10-25

JSE:APN JSE:AVI JSE:ISA

UPDATE 2-S.Africa`s Aspen aims to sharply increase COVID-19 vaccine capacity

* To ramp up to 300 mln doses/yr by Dec, CEO says (Adds details from CEO interview, minister comments)

2021-10-25

JSE:APN JSE:AVI JSE:ISA

S.Africa`s Aspen seeks licence for J&J COVID shot as EU shipments halted

Aspen Pharmacare said on Thursday it was in talks to make Johnson & Johnson`s coronavirus shot under licence in South Africa, at what would be the continent`s first major independent distribution base for a global vaccine against COVID-19.

2021-09-02

JSE:APN JSE:AVI

Facing backlash, EU says import of J&J vaccines from South Africa is temporary

BRUSSELS (Reuters) -The European Commission said on Thursday it had reached a temporary agreement with South Africa to use a plant there to bottle Johnson & Johnson COVID-19 vaccines that are being imported into the EU, after criticism of the arrangement.

2021-08-19

JSE:APN JSE:AVI JSE:ISA

Aspen to start J&J COVID-19 vaccine supplies to South Africa from Monday

JOHANNESBURG (Reuters) -South Africa`s Aspen Pharmacare will supply the first batch of Johnson & Johnson COVID-19 vaccine to the country from July 26, the drugmaker said on Monday.

2021-07-26

JSE:APN JSE:AVI

UPDATE 1-Aspen to start J&J COVID-19 vaccine supplies to South Africa from Monday

South Africa`s Aspen Pharmacare will supply the first batch of Johnson & Johnson COVID-19 vaccine to the country from July 26, the drugmaker said on Monday.

2021-07-26

JSE:APN JSE:AVI

South Africa`s Ramaphosa accuses Big Pharma of `selfish, unjust` vaccine policy

South Africa`s president said on Monday the "selfish, unjust" refusal of pharmaceutical companies and allied Western governments to entertain emergency patent waivers on COVID-19 vaccines was endangering the entire world.

2021-06-21

JSE:APN

J&J to send 2 million COVID-19 vaccine doses to S.Africa by end-June -President Ramaphosa

JOHANNESBURG (Reuters) -South African President Cyril Ramaphosa said on Tuesday that Johnson & Johnson would send 2 million COVID-19 vaccine doses to the country by the end of the month, making up for the amount lost due to contamination at an U.S. ingredient supplier.

2021-06-16

JSE:APN JSE:AVI

UPDATE 1-J&J to send 2 million COVID-19 vaccine doses to S.Africa by end-June -President Ramaphosa

South African President Cyril Ramaphosa said on Tuesday that Johnson & Johnson would send 2 million COVID-19 vaccine doses to the country by the end of the month, making up for the amount lost due to contamination at an U.S. ingredient supplier.

2021-06-15

JSE:APN JSE:AVI

J&J to send S.Africa more than 300,000 vaccine doses, says Aspen

JOHANNESBURG (Reuters) -Johnson & Johnson (J&J) will export more ready-to-administer COVID-19 vaccines to South Africa beyond the 300,000 doses already pledged, the CEO of Aspen Pharmacare said on Monday.

2021-06-14

JSE:APN JSE:AVI JSE:ISA

South African health inspectors will not release unsuitable J&J vaccines

South African health inspectors on Sunday said they will not release Johnson & Johnson COVID-19 vaccines that may have been contaminated during production at a U.S. plant.

2021-06-13

JSE:APN JSE:MPT

South Africa warns of `vaccine apartheid` if rich countries hog shots

South African President Cyril Ramaphosa said on Monday that if wealthy nations hogged COVID-19 shots while millions in poor countries died waiting for them it would amount to "vaccine apartheid".

2021-05-10

JSE:APN JSE:AVI

South Africa`s rand edges higher in thin trade

South Africa`s rand edged higher early on Monday in thin trade ahead of a national holiday, with traders unlikely to take many big bets ahead of some key data due later in the week.

2021-04-26

JSE:APN JSE:CLS JSE:JSE

S.Africa`s Imperial Logistics says it has been selected to import COVID-19 vaccines

South Africa`s largest logistics company Imperial Logistics has been awarded the tender to import COVID-19 vaccines for the second and subsequent phases of the country`s vaccination programme, it told Reuters on Thursday.

2021-04-22

JSE:APN JSE:CLS JSE:DCP

South African business group calls for vaccine focus on elderly

A South African business lobby group called on Monday for the government to shift the emphasis on its vaccine programme to target the elderly and vulnerable sooner, to prevent hospitals being overrun in a third wave of COVID-19 infections.

2021-03-22

JSE:APN JSE:AVI

S.African business group calls for vaccine focus on elderly

* Businesses want elderly to be part of first phase vaccination

2021-03-22

JSE:APN JSE:AVI JSE:ISA

UPDATE 1-Aspen staves off EU antitrust fine with offer to slash cancer drug prices

South Africa`s Aspen Pharmacare Holdings warded off a possible hefty EU antitrust fine after regulators accepted the pharceutical company`s offer to cut cancer drug prices in Europe by about two-thirds in a landmark case aimed at deterring excessive prices.

2021-02-10

JSE:APN JSE:ISA

Exclusive-Aspen to dodge EU antitrust fine with cancer drug price cut offer -sources

South African pharmaceutical company Aspen is set to avoid a potentially hefty EU antitrust fine, with regulators poised to accept its offer to cut cancer drug prices in the coming weeks, two people familiar with the matter said.

2021-02-03

JSE:APN JSE:ISA

South Africa`s rand firms as country secures COVID-19 vaccines

South Africa`s rand firmed on Friday, as investors found some comfort in news that the country has secured COVID-19 vaccines for healthcare workers and that the rollout should start sooner than anticipated after criticism of delays.

2021-01-08

JSE:APN

S.Africa`s two biggest pharmacies plan to offer COVID-19 vaccines

South Africa`s two biggest pharmacy chains Clicks Group and Dis-Chem Pharmacies said they plan to offer COVID-19 shots at their stores and provide storage and distribution facilities in the vaccine rollout programme once the government provides more details.

2021-01-08

JSE:APN JSE:CLS JSE:DCP JSE:AVI

South Africa`s Aspen could produce J&J COVID shots by end-March

Aspen Pharmacare could start production of Johnson & Johnson COVID-19 vaccines in South Africa by late March or early April if all approvals are in place, a senior company executive said.

2021-01-07

JSE:APN JSE:AVI

South Africa`s Aspen agrees initial deal to make J&J vaccine candidate

South African pharmaceutical company Aspen Pharmacare said on Monday it had reached a preliminary agreement with Johnson & Johnson to commercially manufacture its COVID-19 vaccine candidate, sending its shares higher.

2020-11-02

JSE:APN JSE:AVI JSE:ETO JSE:ISA

South Africa`s Aspen to seek acquisitions in emerging markets

South African pharmaceutical major Aspen Pharmacare Holdings Ltd said on Thursday it is planning to expand its portfolio in emerging markets through a mix of organic growth and acquisitions, as part of a new strategy.

2020-09-10

JSE:APN JSE:AVI JSE:MPT

UPDATE 1-S.Africa`s Aspen sells thrombosis drug business to Mylan, shares jump

South African drugmaker Aspen Pharmacare has agreed to sell the rights to its European thrombosis business to U.S. pharmaceutical company Mylan for almost 642 million euros ($759 million), sending its shares up 7% on Tuesday.

2020-09-08

JSE:APN JSE:ETO JSE:ISA

S.Africa`s Aspen says it has capacity to meet demand for dexamethasone

South Africa`s pharmaceutical giant Aspen Pharmacare Holdings Ltd said on Monday the company had sufficient local capacity to produce injections to meet any demand surge for dexamethasone.

2020-06-22

JSE:DSY JSE:APN JSE:AVI

South African drugmaker Aspen expects coronavirus impact

South African drugmaker Aspen Pharmacare Holdings Ltd reported a small rise in earnings in the first half of the 2020 financial year on Thursday and said the coronavirus outbreak would impact its performance.

2020-03-05

JSE:APN JSE:AVI JSE:MPT JSE:ISA

UPDATE 2-South African drugmaker Aspen expects coronavirus impact

* Aspen reviewing manufacturing and procurement processes (Adds coronavirus details, outlook)

2020-03-05

JSE:APN JSE:AVI JSE:MPT JSE:ISA

Novartis buys Aspen`s Japanese generic unit for up to 400 million euros

Novartis is buying the Japanese generics unit of South Africa`s Aspen Pharmacare in a deal worth up to 400 million euros ($440.80 million) to expand in the world`s third-biggest drug market, the Swiss drugmaker said on Monday.

2019-11-11

JSE:APN JSE:ETO JSE:ISA

Aspen`s drug to prevent preterm birth approved by FDA

The U.S. Food and Drug Administration (FDA) has approved Aspen Pharmacare`s hydroxyprogesterone caproate (HPC), which is used to prevent preterm birth in pregnant women, the South African drugmaker`s CEO said on Thursday.

2019-09-12

JSE:APN JSE:AVI JSE:ISA

UPDATE 1-S.Africa`s rand firms on ECB decision, trade hopes, stocks gain

South Africa`s rand rallied in afternoon trade on Thursday as the European Central Bank`s new stimulus measures and mutual concessions by the United States and China in their trade dispute buoyed risk appetite, while stocks also gained.

2019-09-12

JSE:PRX JSE:AGL JSE:NPN JSE:AMS JSE:IMP JSE:APN JSE:ISA

UPDATE 2-Aspen posts lower FY profit on weaker manufacturing results, no dividend

* Intends to restart heparin supply to third-parties (Adds details)

2019-09-11

JSE:APN JSE:AVI JSE:MPT JSE:ISA

South Africa`s Aspen to pay 8 million pounds to NHS after UK probe

British authorities said on Wednesday South Africa`s Aspen Pharmacare Holdings Ltd has agreed to pay the National Health Service (NHS) 8 million pounds ($9.65 million) to resolve concerns related to overpayment for a treatment.

2019-08-14

JSE:APN

South Africa`s Aspen sells Australian prescription portfolio to Mylan

Aspen Pharmacare said on Monday that Mylan NV had exercised an option to buy the South African drugmaker`s portfolio of prescription and over-the-counter products in Australia for 188 million Australian dollars ($130 million).

2019-05-20

JSE:APN

UPDATE 1-South Africa`s rand firms on improved risk appetite, Naspers lift stocks

South Africa`s rand firmed on Monday, helped by increasing demand for emerging market currencies amid a slew of disappointing economic data in developed markets and growth warnings from central banks.

2019-03-11

JSE:NPN JSE:ABG JSE:APN JSE:OMU JSE:TON JSE:ISA

South Africa`s Aspen launches three-in-one HIV drug

South African drugmaker Aspen Pharmacare on Monday launched a triple-combination tablet for the treatment of HIV in the country where the virus is most prevalent.

2018-11-26

JSE:APN JSE:AVI

More information for subscribed users:
detailed calculation of
Potential and Created Value,
website traffic data

Releases

2022-04-06
Dealing in Aspen Securities by a Director, the Company Secretary, and Prescribed Officers of the Company
2022-04-06
Dealing in Aspen Securities by a Prescribed Officer of the Company
2022-04-01
Vesting of securities for directors, company secretary and prescribed officers of the company
2022-03-28
Dealing in Aspen Securities
2022-03-09
Group Financial Results for the six months ended 31 December 2021
2022-03-08
Aspen concludes agreement to manufacture and make available an Aspen-branded Covid-19 vaccine (Aspenovax)
2022-03-08
Appointment of Yvonne Muthien as member of the Social & Ethics Committee
2022-03-01
Completion of divestment of a portfolio of six South African products to Acino
2022-02-28
Aspen’s Interim Results for the six months ended 31 December 2021 and Results presentation reminder
2022-02-01
Trading Statement in respect of Aspen’s results for the six months ended 31 December 2021
2022-01-18
Business update for the six months ended 31 December 2021 and withdrawal of cautionary announcement
2021-12-09
Report on Annual General Meeting proceedings

Documents

SENS Announcements

2024-04-04
Completion of two Transactions with Sandoz
2024-03-08
Appointment of Directors
2024-03-04
Unaudited Interim Group Financial Results for the six months ended 31 December 2023
2024-02-27
Reminder of the Release of Interim Results for the six months ended 31 December 2023 and a Live Presentation Thereof
2024-02-06
Notification in terms of Section 122(3) of the Companies Act and Paragraph 3.83(b) of the JSE Listings Requirements
2024-01-31
Aspen’s Results for the six months ended 31st December 2023 and Results Presentation
2023-12-08
Appointment of Group Company Secretary
2023-12-07
Report on Annual General Meeting Proceedings
2023-12-06
Completion of the Acquisition of Distribution and Promotion Rights from Lilly
2023-12-04
Aspen reaches Agreement on two transactions with Sandoz
2023-11-27
Reminder: Manufacturing Day & Aspen Notre-Dame-De-Bondeville Site Visit – 29th November 2023
2023-11-01
Completion of the Acquisition of a Portfolio of Products in Latin America from Viatris
2023-10-27
Release of Integrated Report, B-BBEE Verification Certificate and Further Notice of Annual General Meeting
2023-10-27
Manufacturing day & Aspen Notre-Dame-De-Bondeville site visit – 29th November 2023
2023-10-23
Vesting of Securities for Directors, Company Secretary and Prescribed Officers of the Company
2023-10-04
No Change Statement and Notice of Annual General Meeting – 7 December 2023
2023-09-27
Notification in terms of section 122(3) of the Companies Act and paragraph 3.83(b) of the JSE Listings Requirements
2023-09-27
Dealings in Securities by Directors, Prescribed Officers and the Company Secretary of the Company
2023-09-19
Contract Manufacturing Agreement To Initiate Local Production Of Human Insulin For Novo Nordisk
2023-09-06
Correction: Contract Manufacturing Agreement to Initiate Local Production of Medicine to Treat a Chronic Disease
2023-09-06
Contract Manufacturing Agreement to Initiate Local Production of an Essential Medicine to treat a Chronic Disease
2023-08-30
Reviewed Condensed Group Financial Results for the year ended 30 June 2023 and Cash Dividend Declaration
2023-08-30
Aspen secures Distribution and Promotion Rights in South Africa and Certain Sub-Saharan African Countries from Lilly
2023-08-17
Reminder of the Release of the Annual Financial Results for the Year ended 30 June 2023 and a Live Presentation
2023-08-01
Acquisition of a Portfolio of Products in Latin America from Viatris
2023-06-14
Changes to the Aspen Board Committees
2023-05-29
Resignation of Ms Babalwa Ngonyama
2023-05-04
Aspen secures distribution rights in South Africa from Amgen
2023-03-13
Notification in terms of section 122(3) of the Companies Act and paragraph 3.83(b) of the JSE Listings Requirements
2023-03-01
Group Financial Results for the six months ended 31 December 2022 and appointment of interim company secretary
2023-02-17
Aspen’s Interim Results for the six months ended 31 December 2022 and Results presentation reminder
2023-01-30
Passing of Company Secretary: Riaan Verster
2022-12-12
Aspen, CEPI and the Bill & Melinda Gates Foundation expand commitments to improve access to vaccines in Africa
2022-12-08
Report on Annual General Meeting proceedings
2022-11-10
Broad-Based Black Economic Empowerment Certificate for the year ended 30 June 2022
2022-11-08
Aspen closes EUR 1.26bn equivalent Syndicated Loan Facilities
2022-11-03
Dealing in Aspen Securities by a Director, Prescribed Officer, and the Company Secretary of the Company
2022-11-01
Notification in terms of Section 122(3) of the Companies Act and paragraph 3.83(b) of the JSE Listings Requirements
2022-10-28
Release of Integrated Report and further notice of Annual General Meeting to be held on 8 December 2022
2022-10-25
Delivery of securities to directors, company secretary, and prescribed officers of the company
2022-10-21
Dealing in Aspen Securities
2022-10-04
Release Of Annual Financial Statements, Change Statement and Notice of Annual General Meeting on 8 December 2022
2022-09-15
Dealing in securities by Directors, Prescribed Officers and the Company Secretary of the Company
2022-08-31
Reviewed Provisional Group Financial Results for the year ended 30 June 2022 and Dividend Declaration
2022-08-31
Aspen concludes a collaboration agreement to manufacture and make available four Aspen-Branded vaccines for Africa
2022-08-23
Reminder of the release of the Annual Financial Results for the year ended 30 June 2022 and a Live Presentation
2022-08-17
Trading Statement for the Financial Year ended 30 June 2022